Home | Contact Us | FAQ | Search & Site Map | Link to Us
Sign In | Join | Other 45 Sites in Network
Home
Discussion Groups
General
GeneralCardiologyVisionDentistryPharmacyLaboratoryNutritionAlternative
Diseases and Disorders
AIDSAlzheimer'sArthritisAsthmaCancerBreast CancerDiabetesEpilepsyGlaucomaHepatitisHerpesLupusProstate BPHProstate CancerProstatitisSinusitisTinnitus

Medical Forum / Diseases and Disorders / AIDS / October 2006

Tip: Looking for answers? Try searching our database.

APTIMA

Thread view: 
Enable EMail Alerts  Start New Thread
Thread rating: 
GMCarter - 18 Oct 2006 16:37 GMT
http://www.hivguidelines.org/Module.aspx?moduleID=18
FDA Approval of APTIMA® HIV-1 RNA Qualitative Assay

October 2006

The Food and Drug Administration (FDA) recently approved APTIMA® HIV-1
RNA Qualitative Assay to detect HIV-1 infection, including acute or
primary infection.

APTIMA is an in vitro nucleic acid test (NAT) used to detect HIV-1
before the appearance of antibodies to HIV-1. APTIMA, used as an aid
in the diagnosis of HIV-1, may provide earlier diagnosis of infection
than traditional testing for anti-viral antibodies by enzyme
immunoassay (EIA) because it detects nucleic acid of HIV-1 in human
plasma, rather than detecting the antibody response to the virus which
may take months between infection and detectable serological levels.
Presence of HIV-1 RNA in the plasma of patients without antibodies to
HIV-1 is indicative of acute or primary HIV-1 infection.

The APTIMA HIV-1 RNA Qualitative Assay may also be used as an
additional test for confirmation of HIV-1 infection in an individual
whose specimens are repeatedly positive for HIV-1 antibodies. This is
important because the Western blot results, traditionally used to
confirm EIA results, are not always conclusive. The APTIMA assay can
be used for the Western blot test or IFA for confirmation of HIV-1
infection when screening test results for HIV-1 antibodies are
positive.

The APTIMA HIV-1 RNA Qualitative Assay is not meant to be used as a
stand-alone test for the diagnosis of HIV-1 infection.  A positive NAT
result indicates probable infection and should be followed up later
with traditional EIA antibody testing to confirm HIV infection.
Sensitivity of the APTIMA HIV-1 RNA Qualitative Assay is comparable to
that of FDA approved viral load assays, but unlike the viral load
tests, the APTIMA test has been approved for the diagnosis of primary
HIV-1 infection, as well as for confirming HIV-1 infection when tests
for antibodies to HIV-1 are positive.

Product labeling for APTIMA HIV-1 RNA Qualitative Assay will be
available soon on the list of FDA Licensed / Approved HIV, HTLV and
Hepatitis Tests on the FDA website.
Death - 18 Oct 2006 16:55 GMT
"GMCarter" <fiar@verizon.net> wrote in message

> The APTIMA HIV-1 RNA Qualitative Assay may also be used as an
> additional test for confirmation of HIV-1 infection in an individual
> whose specimens are repeatedly positive for HIV-1 antibodies.

Hey, now that sounds useful. Another test for people who have tested
positive several times already, kewl.

> The APTIMA HIV-1 RNA Qualitative Assay is not meant to be used as a
> stand-alone test for the diagnosis of HIV-1 infection.

LOL, this is one of those cases where you follow the money trail.
Dildeaux - 18 Oct 2006 20:23 GMT
> "GMCarter" <fiar@verizon.net> wrote in message
>>
[quoted text clipped - 4 lines]
> Hey, now that sounds useful. Another test for people who have tested
> positive several times already, kewl.

Death, George offered a positive contribution to this newsgroup. Here
you once again vomit up your bitter bile.

It is obvious that Death is a deeply depressed unhappy closet case who
should follow the Mark Foley model and check himself in for alcohol
rehab before he hurts himself further.
Death - 18 Oct 2006 21:53 GMT
"Dildeaux" <dildeaux@toys.com> wrote in message

> Death, George offered a positive contribution to this newsgroup.

Yep, ole positive George has contributed his share all right.

What I find amusing is your running to his defense rather than
you  naming the faggot mammals (animals) that buttfuck each other.

I believe the word you used was many. I asked for just one.
Dildeaux - 21 Oct 2006 06:15 GMT
> "Dildeaux" <dildeaux@toys.com> wrote in message
>>
[quoted text clipped - 6 lines]
>
> I believe the word you used was many. I asked for just one.

rats ... just look in the mirror for the closest one.
Death - 21 Oct 2006 16:02 GMT
"Dildeaux" <dildeaux@toys.com> wrote in message

> " Death" <Death@yourdoor.net> wrote in message
> >
[quoted text clipped - 10 lines]
>
> rats ... just look in the mirror for the closest one.

I can look in the mirror and see a mammal, but when I went to college
a rat was a rodent.
You've had several days now to produce what you claim exist.
How many more days do you require to name one buttfucking mammal
other than a faggot.

I understand scientist are now using faggots in the lab.
The advantage to that is they couldn't get the lab rats to
buttfuck each other and the scientist didn't get attached
to the faggots.
Dildeaux - 22 Oct 2006 03:58 GMT
>> rats ... just look in the mirror for the closest one.
>>
> I can look in the mirror and see a mammal,

No - what you see is a minimal.

> but when I went to college

lol!

> a rat was a rodent.

A rodent is a mammal.

> You've had several days now to produce what you claim exist.

I just did, you overachieving elementary school dropout.
GMCarter - 18 Oct 2006 22:20 GMT
>"GMCarter" <fiar@verizon.net> wrote in message
>>
[quoted text clipped - 4 lines]
>Hey, now that sounds useful. Another test for people who have tested
>positive several times already, kewl.

LOL. Yes, that would just be a stupid use of the test.

>> The APTIMA HIV-1 RNA Qualitative Assay is not meant to be used as a
>> stand-alone test for the diagnosis of HIV-1 infection.
>
>LOL, this is one of those cases where you follow the money trail.

For sure. But most tests are not "stand-alone".

This test may help people with suspected acute infection.

Definitely, it needs to be scrutinized more closely as the FDA is
quite corrupt.

        George M. Carter
Death - 18 Oct 2006 22:59 GMT
"GMCarter" <fiar@verizon.net> wrote in message

>  " Death" <Death@yourdoor.net>
> >
[quoted text clipped - 5 lines]
> Definitely, it needs to be scrutinized more closely as the FDA is
> quite corrupt.

The tv is full of lawyers asking people to join in on their, class-action law-suits,
against FDA approved drugs.
It just doesn't seem profitable to pay those kick-backs to the FDA whom can not be sued.
I heard one argument made that if they didn't put the meds out, people would suffer.
Half of the junk for sale will cause liver damage.
Sometimes I guess you have to weigh the risks.
Brian Mailman - 19 Oct 2006 02:24 GMT
> Definitely, it needs to be scrutinized more closely as the FDA is
> quite corrupt.

http://www.cnn.com/2006/POLITICS/10/17/fda.crawford.ap/index.html

B/
Death - 21 Oct 2006 17:47 GMT
"GMCarter" <fiar@verizon.net> wrote in message

> Definitely, it needs to be scrutinized more closely as the FDA is
> quite corrupt.>

washingtonpost.com

"Our evaluation is that the food from cloned animals is as safe as the food we eat every day,"
said Stephen F. Sundlof, the FDA's chief of veterinary medicine, who has overseen the
long-stalled risk assessment.

Farmers and companies that have been growing cloned barnyard animals from single cells in
anticipation of a lucrative market say cloning will bring consumers a level of consistency and
quality impossible to attain with conventional breeding, making perfectly marbled beef and
reliably lean and tasty pork the norm on grocery shelves.

But groups opposed to the new technology, including a coalition of powerful food companies
concerned that the public will reject Dolly-the-Lamb chops and clonal cream in their coffee,
have not given up.

On Thursday, advocacy groups filed a petition asking the FDA to regulate cloned farm animals
one type at a time, much as it regulates new drugs, a change that would drastically slow
marketing approval. Some are also questioning the ethics of a technology that, while more
efficient than it used to be, still poses risks for pregnant animals and their newborns.

"The government talks about being science-based, and that's great, but I think there is another
pillar here: the question of whether we really want to do this," said Carol Tucker Foreman,
director of food policy at the Consumer Federation of America.

That there is a debate at all about integrating clones into the food supply is evidence of the
remarkable progress made since the 1996 birth of Dolly, the world's first mammalian clone,
created from an udder cell of an anonymous ewe.

Scientists have now applied the technique successfully to cattle, horses, pigs, goats and other
mammals. Each clone is a genetic replica of the animal that donated the cell from which it was
grown.

Cloning could solve a number of long-standing farm problems. Many prize males are not
recognized as such until long after they have been tamed by castration. With cloning, that lack
of semen would not matter. Cloning also allows farmers to make many copies of exceptional milk
producers; with natural breeding, cows have only one offspring per year, and half are males.

In the eyes of many in agriculture, cloning is simply the latest in a string of advances such
as artificial insemination and in vitro fertilization that have given farmers better control
over animal reproduction.

"Clones are just clones. They are not genetically engineered animals," said Barbara Glenn,
chief of animal biotechnology at the Biotechnology Industry Organization.

CONTINUED

© 2006 The Washington Post Company
Dildeaux - 22 Oct 2006 03:59 GMT
> "GMCarter" <fiar@verizon.net> wrote in message
>>
[quoted text clipped - 16 lines]
> marbled beef and
> reliably lean and tasty pork the norm on grocery shelves.

But what would Jesus say?
 
Sign In
Join
My Latest Posts
My Monitored Threads
My Blog
My Photo Gallery
My Profile
My Homepage

Start New Thread
Enable EMail Alerts
Rate this Thread



©2008 Advenet LLC   Privacy Policy - Terms of Use
This website includes both content owned or controlled by Advenet as well as content owned or controlled by third parties.